Chemotherapy With Monoclonal Antibody and Radioimmunotherapy for High-Risk B-Cell Non-Hodgkins Lymphoma

NCT00577629 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

39

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma, B-Cell

Interventions

DRUG: cyclophosphamide
DRUG: etoposide
DRUG: rituximab
DRUG: cytarabine
DRUG: doxorubicin
DRUG: tositumomab

Sponsor

Duke University

Collaborators

[object Object]